Despite the evidence that PON1 is involved in atherosclerosis, this has been questioned most vocally because highly purified or recombinant PON1 has lost some or all of its capacity to prevent LDL oxidation whereas it does retain much of its hydrolytic activity towards organophosphate substrates such as paraoxon [2▪▪]. Here, PON1 is linked to atherosclerosis.